Prophylactic tranexamic acid in Cesarean delivery: an updated meta-analysis with a trial sequential analysis

CONCLUSION: Prophylactic TXA administration for parturients undergoing Cesarean delivery significantly reduced blood loss, without increasing adverse events, supporting its use as a safe and effective strategy for reducing PPH in this population.STUDY REGISTRATION: PROSPERO (CRD42023422188); first submitted 27 April 2023.PMID:38453797 | DOI:10.1007/s12630-024-02715-3
Source: Canadian Journal of Anaesthesia - Category: Anesthesiology Authors: Source Type: research